Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IngMar Medical is a global leader in the development and manufacture of high-fidelity respiratory simulators and test lungs. The company's flagship product, the ASL 5000, is widely considered the gold standard for breathing simulation, capable of mimicking complex patient scenarios from neonatal to adult. These tools are essential for ventilator manufacturers in R&D and quality control, as well as for clinicians and educators in advanced mechanical ventilation training. By providing realistic, reproducible lung models, IngMar Medical enables the testing of respiratory therapy devices without the need for human subjects. In 2022, the company was acquired by Laerdal Medical, integrating its specialized respiratory expertise into a broader portfolio of patient simulation solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IngMar Medical.